DISCOUNT-ZERTIFIKAT - JOHNSON & JOHNSON Stock

Certificat

DE000KJ34R08

Market Closed - Boerse Frankfurt Warrants 01:26:08 2024-06-14 pm EDT
129.3 EUR -0.03% Intraday chart for DISCOUNT-ZERTIFIKAT - JOHNSON & JOHNSON
Current month+0.40%
1 month-0.70%
Date Price Change
24-06-14 129.3 -0.03%
24-06-13 129.3 +0.83%
24-06-12 128.3 -1.09%
24-06-11 129.7 +0.10%
24-06-10 129.5 -0.12%

Real-time Boerse Frankfurt Warrants

Last update June 14, 2024 at 01:26 pm EDT

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer Citi Citi
WKN KJ34R0
ISINDE000KJ34R08
Date issued 2024-01-24
Maturity 2025-03-20 (278 Days)
Parity 1 : 1
Emission price 131.2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 133.9
Lowest since issue 126.7

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
145.5 USD
Average target price
171.7 USD
Spread / Average Target
+17.99%
Consensus